Skip to main content
. 2020 Nov 2;11:578002. doi: 10.3389/fgene.2020.578002

Figure 4.

Figure 4

The differentiated expression of CD52, correlation with the survival of BC patients, and gene set enrichment analysis (GSEA). (A) Differentiated expression of CD52 in the normal and BC samples. (B) Paired differentiation analysis for expression of CD52. (C) Survival analysis for BC patients with different CD52 expressions in The Cancer Genome Atlas (TCGA) database. (D) Survival analysis for BC patients with different CD52 expressions in the METABRIC cohort. (E) The top five significant pathways of high and low expressions, respectively.